Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Cell Culture, Engineering and Formulation Techniques

Cecile Geuijen's Biography



Cecile Geuijen, Director, Merus Biopharmaceuticals

Sorry, There is currently no biography for this presenter.

Cecile Geuijen Image

Production of Antibody Mixtures from Single Clonal Cells

Thursday, 21 July 2011 at 10:00

Add to Calendar ▼2011-07-21 10:00:002011-07-21 11:00:00Europe/LondonProduction of Antibody Mixtures from Single Clonal CellsSELECTBIOenquiries@selectbiosciences.com

Oligoclonics™ are mixtures of conventional and bispecific human monoclonal antibodies(hu-mAbs) that bind to different epitopes of single or multiple targets and are produced by a clonal cell. These mixture, represent next-generation biopharmaceuticals with improved efficacy and are based on hu-mAbs that share the same, identical germline-encoded light chain. Merus has developed production technology and analytical tools for the efficient manufacturing and detailed characterization of Oligoclonics™. The generation of OligoclonicsTM and developmental and regulatory aspects of this new format with be discussed.


Add to Calendar ▼2011-07-20 00:00:002011-07-21 00:00:00Europe/LondonCell Culture, Engineering and Formulation TechniquesSELECTBIOenquiries@selectbiosciences.com